330 related articles for article (PubMed ID: 1495006)
21. Regiospecific synthesis and anti-human immunodeficiency virus activity of novel 5-substituted N-alkylcarbamoyl and N,N-dialkylcarbamoyl 1,2,3-triazole-TSAO analogues.
Velázquez S; Alvarez R; Pérez C; Gago F; De Clercq E; Balzarini J; Camarasa MJ
Antivir Chem Chemother; 1998 Nov; 9(6):481-9. PubMed ID: 9865386
[TBL] [Abstract][Full Text] [Related]
22. Side-chain derivatives of biologically active nucleosides. 1. Side-chain analogs of 3'-azido-3'-deoxythymidine (AZT).
Hiebl J; Zbiral E; Balzarini J; De Clercq E
J Med Chem; 1992 Aug; 35(16):3016-23. PubMed ID: 1323681
[TBL] [Abstract][Full Text] [Related]
23. Computational analysis of aza analogues of [2',5'-bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranose]-3'-spiro-5"-(4"-amino-1",2"-oxathiole-2",2"-dioxide) (TSAO) as HIV-1 reverse transcriptase inhibitors: relevance of conformational properties on the inhibitory activity.
Soriano E; Marco-Contelles J; Tomassi C; Nguyen Van Nhien A; Postel D
J Chem Inf Model; 2006; 46(4):1666-77. PubMed ID: 16859298
[TBL] [Abstract][Full Text] [Related]
24. Structure-activity relationships of [2',5'-bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]- 3'-spiro-5' '-(4' '-amino-1' ',2' '-oxathiole-2' ',2' '-dioxide)thymine derivatives as inhibitors of HIV-1 reverse transcriptase dimerization.
Sluis-Cremer N; Hamamouch N; San Félix A; Velazquez S; Balzarini J; Camarasa MJ
J Med Chem; 2006 Aug; 49(16):4834-41. PubMed ID: 16884295
[TBL] [Abstract][Full Text] [Related]
25. The synthesis of branched-chain 3'-C-cyanomethyl-2',3'-dideoxy sugar nucleosides of adenine as potential inhibitors of the human immunodeficiency virus.
Halmos T; Montserret R; Antonakis K
Nucleic Acids Res; 1989 Oct; 17(19):7663-70. PubMed ID: 2798123
[TBL] [Abstract][Full Text] [Related]
26. Suppression of the breakthrough of human immunodeficiency virus type 1 (HIV-1) in cell culture by thiocarboxanilide derivatives when used individually or in combination with other HIV-1-specific inhibitors (i.e., TSAO derivatives).
Balzarini J; Pérez-Pérez MJ; Vélazquez S; San-Félix A; Camarasa MJ; De Clercq E; Karlsson A
Proc Natl Acad Sci U S A; 1995 Jun; 92(12):5470-4. PubMed ID: 7539917
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and antiproliferative and antiviral activity of carbohydrate-modified pyrrolo[2,3-d]pyridazin-7-one nucleosides.
Meade EA; Wotring LL; Drach JC; Townsend LB
J Med Chem; 1997 Feb; 40(5):794-801. PubMed ID: 9057866
[TBL] [Abstract][Full Text] [Related]
28. An approach towards the synthesis of potential metal-chelating TSAO-T derivatives as bidentate inhibitors of human immunodeficiency virus type 1 reverse transcriptase.
Chamorro C; Camarasa MJ; Pérez-Pérez MJ; de Clercq E; Balzarini J; San Félix A
Antivir Chem Chemother; 1998 Sep; 9(5):413-22. PubMed ID: 9875394
[TBL] [Abstract][Full Text] [Related]
29. Identification of a putative binding site for [2',5'-bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]-3'-spiro-5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide)thymine (TSAO) derivatives at the p51-p66 interface of HIV-1 reverse transcriptase.
Rodríguez-Barrios F; Pérez C; Lobatón E; Velázquez S; Chamorro C; San-Félix A; Pérez-Pérez MJ; Camarasa MJ; Pelemans H; Balzarini J; Gago F
J Med Chem; 2001 Jun; 44(12):1853-65. PubMed ID: 11384232
[TBL] [Abstract][Full Text] [Related]
30. Syntheses of 4'-C-ethynyl-beta-D-arabino- and 4'-C-ethynyl-2'-deoxy-beta-D-ribo-pentofuranosylpyrimidines and -purines and evaluation of their anti-HIV activity.
Ohrui H; Kohgo S; Kitano K; Sakata S; Kodama E; Yoshimura K; Matsuoka M; Shigeta S; Mitsuya H
J Med Chem; 2000 Nov; 43(23):4516-25. PubMed ID: 11087576
[TBL] [Abstract][Full Text] [Related]
31. Asymmetric synthesis and biological evaluation of beta-L-(2R,5S)- and alpha-L-(2R,5R)-1,3-oxathiolane-pyrimidine and -purine nucleosides as potential anti-HIV agents.
Jeong LS; Schinazi RF; Beach JW; Kim HO; Nampalli S; Shanmuganathan K; Alves AJ; McMillan A; Chu CK; Mathis R
J Med Chem; 1993 Jan; 36(2):181-95. PubMed ID: 8423591
[TBL] [Abstract][Full Text] [Related]
32. Asymmetric synthesis of 1,3-dioxolane-pyrimidine nucleosides and their anti-HIV activity.
Kim HO; Ahn SK; Alves AJ; Beach JW; Jeong LS; Choi BG; Van Roey P; Schinazi RF; Chu CK
J Med Chem; 1992 May; 35(11):1987-95. PubMed ID: 1597854
[TBL] [Abstract][Full Text] [Related]
33. Design, synthesis and antiviral activity of novel 4,5-disubstituted 7-(beta-D-ribofuranosyl)pyrrolo[2,3-d][1,2,3]triazines and the novel 3-amino-5-methyl-1-(beta-D-ribofuranosyl)- and 3-amino-5-methyl-1-(2-deoxy-beta-D-ribofuranosyl)-1,5-dihydro-1,4,5,6,7,8-hexaazaacenaphthylene as analogues of triciribine.
Migawa MT; Drach JC; Townsend LB
J Med Chem; 2005 Jun; 48(11):3840-51. PubMed ID: 15916436
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and biological evaluation of certain C-4 substituted pyrazolo[3,4-b]pyridine nucleosides.
Sanghvi YS; Larson SB; Willis RC; Robins RK; Revankar GR
J Med Chem; 1989 May; 32(5):945-51. PubMed ID: 2709381
[TBL] [Abstract][Full Text] [Related]
35. Convergent synthesis of polyhalogenated quinoline C-nucleosides as potential antiviral agents.
Chen JJ; Drach JC; Townsend LB
J Org Chem; 2003 May; 68(11):4170-8. PubMed ID: 12762715
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and anti-DNA viral activities in vitro of certain 2,4-disubstituted-7-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)pyrrolo[2,3-d d pyrimidine nucleosides.
Bhattacharya BK; Ojwang JO; Rando RF; Huffman JH; Revankar GR
J Med Chem; 1995 Sep; 38(20):3957-66. PubMed ID: 7562929
[TBL] [Abstract][Full Text] [Related]
37. Human immunodeficiency virus type 1 drug-resistance patterns with different 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine derivatives.
Balzarini J; Karlsson A; De Clercq E
Mol Pharmacol; 1993 Oct; 44(4):694-701. PubMed ID: 7694068
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and antiviral activity of some acyclic and C-acyclic pyrrolo[2,3-d]pyrimidine nucleoside analogues.
Bennett SM; Nguyen-Ba N; Ogilvie KK
J Med Chem; 1990 Aug; 33(8):2162-73. PubMed ID: 2165163
[TBL] [Abstract][Full Text] [Related]
39. Human immunodeficiency virus 1 (HIV-1)-specific reverse transcriptase (RT) inhibitors may suppress the replication of specific drug-resistant (E138K)RT HIV-1 mutants or select for highly resistant (Y181C-->C181I)RT HIV-1 mutants.
Balzarini J; Karlsson A; Sardana VV; Emini EA; Camarasa MJ; De Clercq E
Proc Natl Acad Sci U S A; 1994 Jul; 91(14):6599-603. PubMed ID: 7517553
[TBL] [Abstract][Full Text] [Related]
40. Synthesis of 3'-(4-nitroimidazol-1-yl)-2',3'-dideoxynucleosides of pyrimidine analogues and their biological evaluation against HIV.
Motawia MS; Pedersen EB; Suwinski J; Nielsen CM
Arch Pharm (Weinheim); 1990 Dec; 323(12):949-53. PubMed ID: 2096797
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
